Clearstead Advisors, LLC Danaher Corp Transaction History

Clearstead Advisors, LLC

  • $6.44 Billion
  • Q4 2024

A detailed history of Clearstead Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Clearstead Advisors, LLC holds 88,503 shares of DHR stock, worth $18.2 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
88,503
Previous 87,401 1.26%
Holding current value
$18.2 Million
Previous $24.3 Million 16.39%
% of portfolio
0.32%
Previous 0.39%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
$226.16 - $274.52 $249,228 - $302,521
1,102 Added 1.26%
88,503 $20.3 Million
Q3 2024

Nov 13, 2024
SELL
$239.25 - $280.76 $4,306 - $5,053
-18 Reduced 0.02%
87,401 $24.3 Million
Q2 2024

Aug 09, 2024
BUY
$235.51 - $267.98 $15.9 Million - $18.1 Million
67,467 Added 338.15%
87,419 $21.8 Million
Q1 2024

May 14, 2024
BUY
$224.58 - $256.19 $82,196 - $93,765
366 Added 1.87%
19,952 $4.98 Million
Q4 2023

Feb 12, 2024
BUY
$185.1 - $233.13 $21,841 - $27,509
118 Added 0.61%
19,586 $4.53 Million
Q3 2023

Nov 13, 2023
SELL
$233.08 - $265.59 $768,464 - $875,650
-3,297 Reduced 14.48%
19,468 $4.83 Million
Q3 2023

Nov 07, 2023
BUY
$233.08 - $265.59 $955,161 - $1.09 Million
4,098 Added 21.95%
22,765 $5.65 Million
Q2 2023

Aug 07, 2023
BUY
$224.99 - $256.14 $768,340 - $874,718
3,415 Added 22.39%
18,667 $4.48 Million
Q1 2023

May 09, 2023
BUY
$239.75 - $277.0 $541,595 - $625,743
2,259 Added 17.39%
15,252 $3.84 Million
Q4 2022

Feb 14, 2023
BUY
$241.42 - $282.29 $40,075 - $46,860
166 Added 1.29%
12,993 $3.45 Million
Q3 2022

Nov 14, 2022
SELL
$247.06 - $1507.4 $603,567 - $3.68 Million
-2,443 Reduced 16.0%
12,827 $3.31 Million
Q2 2022

Aug 12, 2022
BUY
$237.11 - $299.66 $241,140 - $304,754
1,017 Added 7.14%
15,270 $3.87 Million
Q1 2022

May 04, 2022
BUY
$257.27 - $315.76 $122,460 - $150,301
476 Added 3.46%
14,253 $4.18 Million
Q4 2021

Feb 14, 2022
BUY
$292.08 - $329.01 $299,674 - $337,564
1,026 Added 8.05%
13,777 $4.53 Million
Q3 2021

Nov 12, 2021
SELL
$272.21 - $332.43 $285,548 - $348,719
-1,049 Reduced 7.6%
12,751 $3.88 Million
Q2 2021

Aug 12, 2021
SELL
$225.08 - $271.69 $15,080 - $18,203
-67 Reduced 0.48%
13,800 $3.7 Million
Q1 2021

May 14, 2021
BUY
$212.38 - $245.9 $115,959 - $134,261
546 Added 4.1%
13,867 $3.12 Million
Q4 2020

Feb 11, 2021
BUY
$212.5 - $245.46 $607,325 - $701,524
2,858 Added 27.32%
13,321 $2.96 Million
Q3 2020

Nov 12, 2020
BUY
$177.16 - $215.33 $4,429 - $5,383
25 Added 0.24%
10,463 $2.25 Million
Q2 2020

Aug 11, 2020
SELL
$128.7 - $176.83 $31,145 - $42,792
-242 Reduced 2.27%
10,438 $1.85 Million
Q1 2020

May 14, 2020
SELL
$121.39 - $169.05 $122,603 - $170,740
-1,010 Reduced 8.64%
10,680 $1.48 Million
Q4 2019

Feb 11, 2020
BUY
$133.47 - $153.48 $155,759 - $179,111
1,167 Added 11.09%
11,690 $1.79 Million
Q3 2019

Nov 12, 2019
SELL
$135.4 - $146.47 $77,313 - $83,634
-571 Reduced 5.15%
10,523 $1.52 Million
Q2 2019

Aug 08, 2019
BUY
$124.88 - $143.73 $8,741 - $10,061
70 Added 0.63%
11,094 $1.59 Million
Q1 2019

May 14, 2019
SELL
$97.62 - $132.29 $32,116 - $43,523
-329 Reduced 2.9%
11,024 $1.46 Million
Q4 2018

Feb 11, 2019
SELL
$94.85 - $109.54 $15,839 - $18,293
-167 Reduced 1.45%
11,353 $1.17 Million
Q3 2018

Nov 13, 2018
SELL
$98.13 - $108.9 $2,453 - $2,722
-25 Reduced 0.22%
11,520 $1.25 Million
Q2 2018

Aug 07, 2018
BUY
$96.1 - $103.24 $28,541 - $30,662
297 Added 2.64%
11,545 $1.14 Million
Q1 2018

May 14, 2018
BUY
$92.16 - $103.8 $2,672 - $3,010
29 Added 0.26%
11,248 $1.1 Million
Q4 2017

Feb 09, 2018
BUY
$85.26 - $94.62 $30,267 - $33,590
355 Added 3.27%
11,219 $1.04 Million
Q3 2017

Nov 09, 2017
BUY
$79.29 - $88.45 $861,406 - $960,920
10,864
10,864 $932,000

Others Institutions Holding DHR

# of Institutions
2,542
Shares Held
555M
Call Options Held
7.24M
Put Options Held
4.28M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $150B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email